Search Engine Submission - AddMe تحميل علوم طبية medical sciences download: Viral Outgrowth Assay Developed for Latent HIV

الخميس، 20 يونيو 2013

Viral Outgrowth Assay Developed for Latent HIV

Viral Outgrowth Assay Developed for Latent HIV

By Labmedica International staff writers
Posted on 14 Jun 2013
Image:  Scanning electron micrograph of HIV-1 virions budding from a lymphocyte (Photo courtesy of C. Goldsmith).
Image: Scanning electron micrograph of HIV-1 virions budding from a lymphocyte (Photo courtesy of C. Goldsmith).
  
The development of a simpler assay for the latent reservoir of human immunodeficiency virus (HIV) has been identified as a major priority in the study of acquired immunodeficiency syndrome (AIDS).
 A rapid viral outgrowth assay that quantifies the frequency of cells that can release replication-competent virus following cellular activation has been developed and validated using a novel quantitative molecular technique.


Scientists at Johns Hopkins University School of Medicine (Baltimore, MD, USA) enrolled 20 HIV-1 infected patients in a study and peripheral blood mononuclear cells (PBMC) were isolated using density gradient centrifugation. CD4+ T lymphocytes were enriched by negative depletion. For each patient, both a standard viral outgrowth assay and a MOLT-4/CCR5 viral outgrowth assay were performed using freshly purified resting CD4+ T lymphocytes obtained from a single blood draw. Resting CD4+ T lymphocytes were further enriched through negative depletion of cells using specific microbeads (Miltenyi Biotec; Auburn, CA, USA).

Complementary DNA (cDNA) was synthesized from the isolated HIV-1 RNA using the SuperScript III First-Strand Synthesis System (Invitrogen, Grand Island, NY, USA) with oligo-dT primers. The assay employs a novel quantitative reverse transcription polymerase chain reaction (RT-PCR) specific for polyadenylated HIV-1 RNA for virus detection, which is a more sensitive and cost-effective method to detect HIV-1 replication than expensive commercial enzyme-linked immunosorbent assay (ELISA) detection methods.

On average, viral outgrowth from the latent reservoir under conditions resembling the MOLT-4/CCR5 viral outgrowth assay was detectable by the HIV-1 specific RT-PCR assay after six days versus 10 days for HIV-1 p24 antigen ELISA. There was no significant difference between the frequency of latent infection of resting CD4+ T cells as measured at day seven using HIV-1 specific RT-PCR and at day 14 as measured by HIV-1 p24 antigen ELISA. The utilization of an RT-PCR based measurement for HIV-1 outgrowth not only allows more sensitive detection of viral replication but also will allow higher throughput measurement of HIV-1 replication.

The authors concluded that the MOLT-4/CCR5 utilizing viral outgrowth assay is the most rapid and scalable assay available for measuring the size of the HIV-1 latent reservoir. As such, they believe that this assay will be an indispensable tool in evaluating the success of strategies to curtail or eradicate the HIV-1 latent reservoir. The study was published on May 30, 2013, in the journal Public Library of Science Pathogens.


Related Links:

Johns Hopkins University School of Medicine

Miltenyi Biotec
Invitrogen
 

ليست هناك تعليقات:

إرسال تعليق